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Identity 
HGNC (Hugo): GFI1B 
Location: 9q34.13 
Local order: The human GFI1B gene is telomeric to 
TSC1 (tuberous sclerosis 1 protein) and centromeric to 




The GFI1B gene structure is composed of at least 7 
exons (ranging from 120 to 824 bp), six of which are
coding. Spliced ESTs and human mRNAs may define 
up to eight additional 5'exons which possibly point to 
an alternative promoter close to the promoter of TSC1. 
Transcription 
Two human mRNA transcripts arise from alternative 
splicing. GFI1B mRNA variant one encodes the more 
frequent full length GFI1B (330 aa), while variant two 
lacks the in frame exon 5 (according to the NCBI 
RefSeq for hGFI1B) leading to a shorter isoform (284 
aa) lacking zinc-finger two and parts of zinc-finger one 
and three. The residual parts of Znf one and three a  






The longer GFI1B variant 1 is the protein refered to in 
most cases. GFI1B variant 2 shows only a restricted 
expression in normal cells and could be preferentially 
associated with leukemic diseases. Functional 
differences between both proteins are not described yet. 
Description 
GFI1B (isoform 1) is a protein of 330 aa residues and
has a predicted molecular mass of 37492.38 Da. 
Isoelectric point: 9.3076, charge: 25.0, average residue 
weight: 113613. 
GFI1B is composed of a 20-amino-acid N-terminal 
SNAG (SNAIL-GFI) transcription repressor domain, 
and intermediary domain of largely unknown function 
and six c-terminal C2H2 zinc-finger domains 
encompassing residues 163-327. Zinc-fingers 3-5 are 
involved in sequence specific DNA binding and 
recognize a taAATCaca/tgca/t core motif. The bases 
flanking the AATC core motif seem to be poorly 
conserved. Predictions of true GFI1B binding sites n 
the genome based only on this sequence have to be 
validated independently. 
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Model for the generation of the two major GFI1B isoforms. GFI1B-V2 is translated from a shorter mRNA splice variant where exon 9 
is skipped (aa 171-216 missing). There are many potential 5' transcriptional start sites, but the major start site seems to be in exon 5, 
corresponding to exon 1 (122 bp) in the RefSeq database. 
SD: SNAG domain necessary for repression of transcription by GFI1B. 
ID: Intermediary domain with very low homology to the GFI1B homolog GFI1 and unknown function, which is presumably important for 
specific protein-protein interactions unique to GFI1B. 
Znf 1-6: C2H2 zinc-finger domains which are highly conserved between all members of the GFI1 protein family. Znf 3-5 bind to the major 




GFI1B is mainly expressed in the fetal and adult 
hematopoietic system, where it is detected in 
hematopoietic stem cells, megakaryocyte/erythroid 
precursors (MEP), common myeloid precursors (CMP), 
erythroblasts and early erythrocytes, megakaryocytes 
and megakaryocyte precursors, B-cell precursors and a 
small subset of T-cell precursors (Vassen et al., 2007). 
GFI1B is lso detected in fetal thymus and testes. GFI1B 
expression varies throughout the maturation of these 
cells, with the highest expression levels in MEPs, 
megakaryocytes and erythrocytes and seems to be 
tightly regulated. The shorter isoform 2 of GFI1B is 
lowly expressed in normal cells, but upregulated in 
several types of leukemia (e.g. chronic myelogenous 
leukemia, acute myeloid leukemia, erythroleukemia, 
megakaryocytic leukemia). The expression of GFI1B is 
described to be positively regulated by GATA-1, NF-
Y, E2-alpha/TCF3, and HMGB2 and to be repressed by 
Oct1, GFI1B and GFI1. GFI1B expression is down-




Almost exclusively nuclear, frequently accumulating  
foci of pericentric heterochromatin. 
Function 
Negative regulation of transcription. GFI1B is an 
essential factor in erythroid and megakaryocytic 
development and differentiation, very likely with proto-
oncogenic potential. GFI1B deficiency leads to 
embryonic lethality in mice due to failure to produce 
functional erythrocytes and megakaryocytes and 
increases the apoptosis rate in leukemic cell lines. The 
GFI1B gene locus can be autoregulated by 
autorepression of its own promoter in hematopoietic 
cells (Vassen et al., 2005; Anguita et al., 2010), most 
likely by interaction with GATA1 (GATA binding 
protein 1) (Huang et al., 2005), an activator of GFI1B 
transcription that is also essential for erythroid and 
megakaryocytic development. GFI1B and its homolog 
GFI1 show cross-repression, resulting in an enhanced 
expression of the respective counterpart, when one of 
these genes is deleted. The repressory activity of 
GFI1B is achieved by recruiting histone deacetylases 
(HDAC1 and HDAC2), lysine specific demethylase 1 
(LSD1 or KDM1) and the REST corepressor 
(CoREST) to target DNA sequences (Saleque et al., 
2007). GFI1B alters histone methylation at target gene 
promoters and is associated with sites of gamma-
satellite containing heterochromatin (Vassen et al.,
2006). GFI1B interacts also with the histone 
methyltransferases G9a and SUV39H1 and a role in  
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heterochromatin formation is hypothesized (Vassen et 
al., 2006). GFI1B target genes (e.g. BCL2L1, SOCS1, 
SOCS3, CDKN1A, GATA3) are frequently also 
GATA1 target genes (e.g. GFI1B, GATA2, Myb, Myc) 
and GFI1B is overrepresented at sites where GATA1 
binds to repress its target genes (Yu et al., 2009). 
GATA2 needs to be repressed by GATA1 in 
developing erythroid cells pointing to an involvement 
of a GATA1-GFI1B repressory complex in this 
process. GATA1 and GFI1B have been found in a 
complex with SUZ12, a member of the polycomb 
repressory complex 2 (PRC2, SUZ12 and Eed) on 
repressed genes in MEL (erythroleukemia) cells (Yu et 
al., 2009). Since GFI1B is also expressed in 
hematopoietic stem cells (HSC), the existence of such a 
repressory complex might point to a role of GFI1B in 
maintaining HSC self renewal, where PCR complexes 
play a major role. Consistent with this hypothesis, 
GFI1B can functionally replace GFI1 during 
hematopoiesis but not in the development of inner ear 
hair cells, where GFI1 exerts a critical survival function 
(Fiolka et al., 2006; Wallis et al., 2003). An implication 
of GFI1B in sensory epithelial cells similar to GFI1 
remains to be elucidated. In megakaryocytes GFI1B is 
found in a complex with GATA1 and ETO2, another 
corepressor protein that is also implicated in human 
leukemogenesis (Hamlett et al., 2008), but how GFI1B 
regulates megakaryocytic development is not clear yt. 
GFI1B regulates TGF-beta signaling in bipotent 
erythroid-megakaryocytic progenitors (Randrianarison-
Huetz, 2010), which is involved in the control of their 
differentiation. Finally, GFI1B regulates the expression 
of GATA3 in T-cell lymphomas, a critical factor for 
survival of lymphomas and T-cell progenitors (Wei and 
Kee, 2007).  
Positive regulation of transcription. GFI1B can 
activate transcription from a promoter containing four 
GFI1 consensus-sites in the erythroid cell line K562 
(Osawa et al., 2002). 
Homology 
GFI1B is highly homologous to its closest relative 
GFI1. Highly conserved GFI1(B) proteins have been 




A single base mutation in the GFI1B promoter (T-C) 
was detected affecting a potential Oct-1 binding site in 
an acute lymphoblastic leukemia patient. The mutation 
was shown to affect the promoter activity, leading to an 
increased expression of GFI1B. (Hernández et al., 
2010). 
Somatic 
A natural variant (p.R231H) was detected in a 
colorectal cancer sample. A GFI1B promoter mutation 
was detected in an acute myeloid leukemia M5a 
patient, affecting a GATA1 binding site which was 
previously shown to be involved in the regulation of 




GFI1B was shown to be highly overexpressed in 
various leukemias (Elmaagacli et al., 2007; Vassen et 
al., 2009). Knock down of GFI1B in leukemia cell lines 
markedly increased the apoptosis rate of these cells 
(Elmaagacli et al., 2007), pointing to a role of GFI1B in 
protection against apoptosis. Overexpression of GFI1B 
in human CD34+ hematopoietic progenitors induced an 
expansion of erythroblasts, independent from 
erythropoietin, pointing to a role of GFI1B in 
regulation of proliferation (Osawa et al., 2002). Since 
reduced apoptosis and enhanced proliferation both are 
involved in leukemogenesis, GFI1B may play an 
important role in these diseases. Additionally, the 
GFI1B locus was found in a retroviral insertion 
mutagenesis screen for factors, cooperating with EGR1 
haploinsufficiency to induce myeloid leukemias in the 
mouse (Quian et al., 2010). 
Disease 
Chronic myeloid leukemia (CML), essential 
thrombocythemia (ET), myelodysplastic syndrome 
(MDS), myeloproliferative syndrome (MPS), B-cell 
acute lymphocytic leukemia (B-ALL), acute myeloid 




Translocated along with ABL1 in chronic myeloid 
leukemia with translocation t(9:22). 
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